Abiopharma

🔍 Kremer Melissa K (Executive)

Company: TARGET CORP (TGT)

Report Date: 2026-08-24

Detailed Transactions and Holdings:

• Sold 15,500 shares of Common Stock at $169.956 per share (Direct)
  Date: 2026-08-24 | Code: S | equity_swap_involved: 0 | shares_owned_after: 56,981.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: Price is the volume weighted average selling price of all sales by the reporting person on the transaction date within a one dollar range. Actual prices ranged from $169.9300 to $170.0000. The reporting person hereby undertakes to provide upon request of the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
• F2: Includes dividend equivalents paid on restricted stock units and performance-based restricted stock units since the date of the reporting person's last filing through the date of the reported transaction that have been reinvested in additional restricted stock units and performance-based restricted stock units.